| Identification | Back Directory | [Name]
Cefprozil-d4 (E/Z mixture) | [CAS]
1426173-48-9 | [Synonyms]
Cefzil-d4
Procef-d4
Prozef-d4
BMY 28100-d4
Cefprozile-d4
Cephprozyl-d4
Cefprozil-d4 (E/Z mixture)
(6R,7R)-7-[[(2R)-2-AMino-2-(4-hydroxyphenyl-d4)acetyl]aMino]-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | [Molecular Formula]
C18H19N3O5S | [MOL File]
1426173-48-9.mol | [Molecular Weight]
389.43 |
| Hazard Information | Back Directory | [Uses]
Labelled Cefprozil. Semisynthetic oral cephalosporin consisting of approx. 90:10 Z/E isomeric mixture. Antibacterial. | [IC 50]
β-lactam | [References]
[1] K TOMATSU. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.[J]. Journal of Antibiotics, 1987, 40 8: 1175-1183. DOI: 10.7164/antibiotics.40.1175
[2] MIHAELA PERIC BS . Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: Use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents[J]. Clinical therapeutics, 2003, 25 1: Pages 169-177. DOI: 10.1016/s0149-2918(03)90021-x
[3] K. NAGAI. Effects of Amino Acid Alterations in Penicillin-Binding Proteins (PBPs) 1a, 2b, and 2x on PBP Affinities of Penicillin, Ampicillin, Amoxicillin, Cefditoren, Cefuroxime, Cefprozil, and Cefaclor in 18 Clinical Isolates of Penicillin-Susceptible, -Intermediate, and -Resistant Pneumococci[J]. Antimicrobial Agents and Chemotherapy, 2002, 46 1: 1273-1280. DOI: 10.1128/aac.46.5.1273-1280.2002 |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|